Dipna Pharmachem Ltd
Dipna Pharmachem Ltd (DPL) last reported results for the quarter ended Mar 2026, with sales of ₹2.05 crore and net profit of ₹0.18 crore. The stock last traded at ₹4.21, a market capitalisation of ₹11.1 crore, on a P/E of 4.21. Over the past 52 weeks the stock has ranged between ₹3.9 and ₹25. Figures are as of 6 Oct 2026 and are not real time.
Dipna Pharmachem Ltd share price and key metrics
- Current price
- ₹4.21
- Market cap
- ₹11.1 cr
- Stock P/E
- 4.21
- Book value
- ₹23.7
- ROE
- 5.22%
- ROCE
- 7.64%
- Dividend yield
- 0.00%
- 52w high / low
- 25.0/3.90
Metrics as of 6 Oct 2026. Not real time.
Track Dipna Pharmachem Ltd
Cruxal reads every Dipna Pharmachem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Dipna Pharmachem Ltd growth and returns
- 10 Years
- %
- 5 Years
- 33%
- 3 Years
- 9%
- TTM
- 4%
- 10 Years
- %
- 5 Years
- 165%
- 3 Years
- 42%
- TTM
- 171%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -29%
- 1 Year
- -80%
- 10 Years
- %
- 5 Years
- 5%
- 3 Years
- 4%
- Last Year
- 5%
Dipna Pharmachem Ltd quarterly results
| ₹ crore | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 15.92 | 53.52 | 2.05 |
| Expenses | 14.64 | 51.87 | 1.59 |
| Operating profit | 1.28 | 1.65 | 0.46 |
| OPM % | 8.04% | 3.08% | 22.44% |
| Other income | 0 | 0 | 0 |
| Interest | 0.6 | 0.23 | 0.23 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 0.68 | 1.42 | 0.23 |
| Tax % | 26.47% | 26.06% | 21.74% |
| Net profit | 0.5 | 1.04 | 0.18 |
| EPS (₹) | 0.21 | 0.40 | 0.07 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dipna Pharmachem Ltd annual results
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 17 | 20 | 30 | 31 | 73 | 100 | 164 | 125 | 129 |
| Operating profit | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 5 |
| OPM % | 2.4% | 2.4% | 1.5% | 1.3% | 3.0% | 2.4% | 2.1% | 3.0% | 3.9% |
| Net profit | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 3 |
| EPS (₹) | 6.00 | 3.00 | 6.00 | 2.00 | 117.00 | 0.37 | 0.45 | 0.40 | 1.00 |
TTM is the trailing twelve months to the most recent quarter.
Dipna Pharmachem Ltd balance sheet
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 12 | 24 | 24 | 26 |
| Reserves | 0 | 0 | 1 | 1 | 2 | 12 | 13 | 14 | 36 |
| Borrowings | 5 | 6 | 10 | 12 | 10 | 16 | 19 | 17 | 13 |
| Other liabilities | 6 | 8 | 8 | 12 | 24 | 37 | 76 | 77 | 130 |
| Total liabilities | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 206 |
| Fixed assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 206 |
| Total assets | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 206 |
As reported by the company. Total assets equal total liabilities by construction.
Dipna Pharmachem Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -3 | -2 | 3 | -21 | -5 | -9 | -18 |
| Cash from investing | 0 | 0 | -0 | -0 | -0 | -0 | -0 |
| Cash from financing | 3 | 2 | -3 | 26 | 14 | -4 | 19 |
| Net cash flow | 0 | 0 | -0 | 5 | 8 | -13 | 0 |
| Free cash flow | -3 | -2 | 3 | -21 | -5 | -9 | -18 |
| CFO / operating profit | -693% | -618% | 148% | -893% | -157% | -246% | -347% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Dipna Pharmachem Ltd operating ratios
| Per year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 8% | 5% | 3% | 17% | 9% | 7% | 7% | 8% |
| Debtor days | 132 | 160 | 134 | 176 | 135 | 104 | 69 | 135 | 136 |
| Inventory days | 112 | 66 | 70 | 89 | 34 | 72 | 86 | 88 | 144 |
| Days payable | 142 | 148 | 105 | 145 | 123 | 139 | 172 | 243 | 375 |
| Cash conversion cycle | 103 | 78 | 99 | 120 | 46 | 38 | -17 | -20 | -95 |
| Working capital days | 3 | 6 | 44 | 47 | 37 | 108 | 80 | 137 | 56 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Dipna Pharmachem Ltd shareholding pattern
Promoters held 9.13% at Jun 2026, down from 9.98% at Mar 2025.
| % held | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Nov 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 57.19% | 9.98% | 9.98% | 9.98% | 9.98% | 9.13% | 9.13% | 9.13% |
| Public | 42.81% | 90.02% | 90.02% | 90.01% | 90.02% | 90.87% | 90.88% | 90.86% |
| No. of shareholders | 1,078 | 1,807 | 2,652 | 1,997 | 1,742 | 1,741 | 1,717 | 1,788 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dipna Pharmachem Ltd corporate filings
- Intimation of Closure of Trading WindowInsider Trading / SASTlow impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.